Signaling lymphocytic activation molecules Slam and cancers: friends or foes?

Signaling Lymphocytic Activation Molecules (SLAM) family receptors are initially described in immune cells. These receptors recruit both activating and inhibitory SH2 domain containing proteins through their Immunoreceptor Tyrosine based Switch Motifs (ITSMs). Accumulating evidence suggest that the...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Fouquet, Gregory, Marcq, Ingrid, Debuysscher, Véronique, Bayry, Jagadeesh, Rabbind Singh, Amrathlal, Bengrine, Abderrahmane, Nguyen-Khac, Eric, Naassila, Mickael, Bouhlal, Hicham
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2018
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5882332/
https://ncbi.nlm.nih.gov/pubmed/29662641
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.24575
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars